曲格列酮对糖耐量受损的肥胖受试者是否真的适用？ - Suppr | 超能文献

Is troglitazone a real indication for obese subjects with impaired glucose tolerance?

作者信息

Yoshioka K, Yokoo S, Yoshida T, Kondo M

出版信息

Diabetes Care. 1997 Aug;20(8):1340-1. doi: 10.2337/diacare.20.8.1340b.

DOI:10.2337/diacare.20.8.1340b

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Is troglitazone a real indication for obese subjects with impaired glucose tolerance?曲格列酮对糖耐量受损的肥胖受试者是否真的适用？

Diabetes Care. 1997 Aug;20(8):1340-1. doi: 10.2337/diacare.20.8.1340b.

2

Effects of troglitazone on insulin sensitivity.曲格列酮对胰岛素敏感性的影响。

Diabet Med. 1996 Sep;13(9 Suppl 6):S148-50.

3

Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.曲格列酮：对其在糖耐量受损和糖尿病患者治疗中作用的综述与评估

Ann Pharmacother. 1998 Mar;32(3):337-48. doi: 10.1345/aph.17046.

4

Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes.2型糖尿病高危女性胰腺β细胞对胰岛素敏感性改善的反应。

Diabetes. 2000 May;49(5):782-8. doi: 10.2337/diabetes.49.5.782.

5

Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.曲格列酮对非胰岛素依赖型糖尿病高危女性胰岛素敏感性及胰岛β细胞功能的影响。

Diabetes. 1996 Nov;45(11):1572-9. doi: 10.2337/diab.45.11.1572.

6

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.使用曲格列酮治疗的肥胖受试者的糖耐量和胰岛素抵抗得到改善。

N Engl J Med. 1994 Nov 3;331(18):1188-93. doi: 10.1056/NEJM199411033311803.

7

Effect of troglitazone on lipoprotein(a) levels in obese subjects.

Diabetes Care. 1999 Oct;22(10):1752-3. doi: 10.2337/diacare.22.10.1752.

8

The role of troglitazone in treating the insulin resistance syndrome.曲格列酮在治疗胰岛素抵抗综合征中的作用。

Pharmacotherapy. 1998 Sep-Oct;18(5):973-87.

9

Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone.使用噻唑烷二酮类药物曲格列酮治疗可使糖耐量受损恢复正常。

Diabetes Care. 1997 Feb;20(2):188-93. doi: 10.2337/diacare.20.2.188.

10

International Diabetes Federation meeting, 1997. Issues in the treatment of type 2 diabetes; sulfonylureas, metformin, and troglitazone.1997年国际糖尿病联盟会议。2型糖尿病的治疗问题；磺脲类药物、二甲双胍和曲格列酮。

Diabetes Care. 1998 Jun;21(6):1024-6. doi: 10.2337/diacare.21.6.1024.

引用本文的文献

1

Troglitazone: a review of its use in the management of type 2 diabetes mellitus.曲格列酮：用于2型糖尿病管理的综述

Drugs. 1999 Mar;57(3):409-38. doi: 10.2165/00003495-199957030-00014.